MSB Trading - 2020, page-16256

This will go sub-$2.00 in no time. Read my old posts on the MSB forum that I got scolded for.

The FDA almost never green lights stem cell therapies, why would they now when we’re 6-8 months away from a COVID vaccine and there are dozens of therapies showing promise? If your argument is that the bigger opportunity for MSB is outside of COVID then you have to agree management was very opportunistic with the headline of that small ~12 person study result. If the COVID press release didn’t exist this would probably be a $1.50 stock.

I’d go as far as to say even if the upcoming COVID trial results are great, it won’t do much for the stock.

MSB isn’t a good hold in my opinion.